We use cookies to ensure that we give you the best experience on our website.

Cookies Notice


A cookie is a small piece of text that allows a website to recognize your device and maintain a consistent, cohesive experience throughout multiple sessions. If you visit EDAN pages, both EDAN and third parties will use cookies to track and monitor some of your activities, and store and access some data about you, your browsing history, and your usage of the EDAN pages.


This policy describes how both EDAN and other third parties use cookies and how you can exercise a greater degree of control over cookies. Please keep in mind that this may alter your experience with our website, and may limit certain features.

General Browsing: We use cookies that are important for certain technical features of our website, like implementing fixes and improvements to our platform.

These cookies:

    - Enable behavior in our Products or Services that is tailored to the activity or preferences of a person visiting our properties

    - Allow users to opt out of certain types of modeling or personalization in our products

    - Collect information on our users’ preferences in order to create more useful products

    - Maintain the regular business operations of our Advertising and Marketing departments

    - Help to diagnose and correct downtime, bugs, and errors in our code to ensure that our products are operating efficiently

Analytics: We use cookies to compile usage activity in order to better cater our Products and Services offerings to you, and to third parties. We DO NOT share identifiable “raw” data with our clients or any third parties, however we do make high-level decisions based on aggregated data about your usage of our Products and Services.

These cookies:

    - Monitor site traffic and behavior flows of users

    - Measure the effectiveness of products

    - Measure the effectiveness of off-site marketing campaigns and tactics


In general, we collect most data from you via form submission. However, there are cases when visiting our site and/or using our platforms in which we may receive certain information through the use of cookies. This data will generally not include personally identifying information about you.

    - Unique identification tokens

    - User preferences such as favorite tags (for anonymous users only)

Third Party Cookies

The use of cookies, the names of cookies, and other cookies related cookies technology may change over time and EDAN will make all reasonable efforts to notify you by updating our cookies table where material changes occur and from time-to-time.


If you don’t want EDAN to use cookies when you visit EDAN home pages, you can opt-out of certain cookie related processing activities when you visit the pages. If you opt-out of cookies, we have to set a cookie to tell us that. Please note that EDAN may not work properly and you may have diminished functionality if you opt-out of certain cookies.If you decide that you do not want cookies to be set on your device by our third-party Partners, you can adjust the settings on your internet browser and choose from the available Cookies setting to best meet your preferences. While setting options may vary from browser to browser, you can generally choose to reject some or all cookies, or instead to receive a notification when a cookie is being placed on your device. For more information, please refer to the user help information for your browser of choice. Please keep in mind that cookies may be required for certain functionalities, and by blocking these cookies, you may limit your access to certain parts or features of our sites. You can manually delete the cookies at any time.

Company News Exhibitions & Events COVID-19 Product Insights

EDAN in India: Strive for Easy Access to Better Health Care



India is a hub for pharmaceutical and biotechnology industries; world-class scientists, clinical trials and hospitals, yet the country faces daunting public health challenges. India's population in 2021 is 1.39 billion, and rural India contains over 68%. Out of the existing over 55,000 laboratories in India, more than 40,000 laboratories are in Tier II and Tier III segments, covering the rural and semi-urban population with limited access to the majority of In-Vitro Diagnostics technologies.

As a basic test to evaluate a patient’s general health status, the penetration of complete blood count (CBC) in rural areas will help to assess the prevalence of various anemia (which is one of the major concerns in India) among the rural population and its control. An affordable and accurate hematology analyzer is the need of the hour. Therefore, local healthcare organizations take note of EDAN with the appreciation for providing a comprehensive solution of Hematology tailored to different user needs.

Cooperation with Local Teaching Hospitals by Comprehensive Hematology Product Matrix

After noticing that the benefits of IVD technologies remain underserved to the patients in these rural areas, EDAN's first step is to work towards enabling medical facilities in remote areas can access blood analyzers with limited resources. To meet the demands of the local market, EDAN IVD team chose H60S and H30 Pro, two newly released products in the past two years, to cooperate with local hospitals in India.

Koppal Institute of Medical Sciences, referred to KIMS Koppal, is one of the privileged medical institutes in Karnataka State. It was established in 2003, affiliated with the Rajiv Gandhi University of Health Sciences, and approved by the NMC. KIMS Koppal has over 450 teaching beds and receives 650 outpatients daily. A batch of 5-part Hematology Analyzer, H60S, and 3-part Hematology Analyzer, H30 Pro, has been installed into the hospital and received positive comments.

“EDAN H60S can reach 300 daily samples in our hospital. The accuracy and speed of testing are both highly improved by the 5-part analyzer. It truly helps us to achieve better education outcomes and inspire our students with high-end models in the field.” Said staff from the teaching hospital.

EDAN H60S & H30 Pro in India.png

Since India is a populous country, those low to moderate-volume laboratories are often overloaded. To address this challenge, H60S is equipped with a few automatic features, such as automatic rotation and recognition of sample ID and 60 samples capacity autoloader with continuous loading, which can lighten the workload for clinicians.

“Automation, being the primary focus of the hematology testing, the market has been witnessing considerable technological advancements with respect to products that offer effective, accurate, and fast testing results,” Said Bo Wang, the IVD Marketing Manager of EDAN. "H60S hematology analyzer has further reduced results delivery time, making the process more effective and efficient in disease diagnosis, and enabling clinicians to get more done in their daily work."

Efforts to Achieve Broader Accessibility of Reliable Hematology Analyzers

In wider areas of rural India, more resource-constrained medical institutions opt for the cost-effective Hematology Analyzers, H30 Pro. As a 3-part analyzer, H30 Pro provides sufficient information in most clinical settings. With up to 120 days of board stability, zero complex maintenance, customizable printout format, and the improved fluidic system reducing reagent consumption, H30 Pro can well suit users’ needs with clinical values and effective cost control. 

“The major change in the hematology segment is the introduction of highly compact 3-part and 5-part hematology systems. These compact systems are well suited for rural India, and are expected to bring in changes in the IVD industry.” Said Dr. Sunita Deshmukh, Head of Lab Sciences & Blood Bank Dept, Paras Hospitals.

By insisting on field visits to access end-users' feedback, EDAN team built a direct connection between the brand and local audiences, which also benefitted the sustained upgrading and development of IVD products.

Clients Feedback on EDAN Hematology Analyzer.png

Hematology analyzers are the real workhorse of clinical laboratories. EDAN will keep working on the development of hematology clinical applications in India, extending the reach of hematology analyzers to laboratories in remote areas, and adding more value to local patient care.